XAD - Xelox (Capecitabine + Oxaliplatin) + Bevacizumab + Dasatinib
Clinical trial NCT00920868 · COMPLETED
Trial details
- NCT number
- NCT00920868
- Sponsor
- Herbert Hurwitz, MD
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-05-01
- Primary completion
- 2010-05-01
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.